Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study
Nicola N. Lynskey, Elita Jauneikaite, Ho Kwong Li, et al.
The Lancet Infectious Diseases (2019) Vol. 19, Iss. 11, pp. 1209-1218
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Pathogenesis, epidemiology and control of Group A Streptococcus infection
Stephan Brouwer, Tania Rivera-Hernández, Bodie F. Curren, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 7, pp. 431-447
Open Access | Times Cited: 199
Increase in invasive group A streptococcal infection notifications, England, 2022
Rebecca Guy, Katherine L. Henderson, Juliana Coelho, et al.
Eurosurveillance (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 138
Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA
Mark R. Davies, Nadia Keller, Stephan Brouwer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 74
Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023
Thor Bech Johannesen, Charlotte Munkstrup, Sofie Marie Edslev, et al.
Eurosurveillance (2023) Vol. 28, Iss. 26
Open Access | Times Cited: 69
Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023
Catarina Gouveia, Maria Paula Bajanca-Lavado, Rafael Mamede, et al.
Eurosurveillance (2023) Vol. 28, Iss. 36
Open Access | Times Cited: 53
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study
Adela Alcolea-Medina, Luke B. Snell, Christopher Alder, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 887-890
Open Access | Times Cited: 51
Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes
Ana Vieira, Yu Wan, Yan Ryan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 49
National case series of group A streptococcus pleural empyema in children: clinical and microbiological features
Victoria Holdstock, Jonathan Twynam-Perkins, Timothy Bradnock, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 2, pp. 154-156
Open Access | Times Cited: 47
Novel insights into the immune response to bacterial T cell superantigens
Stephen W. Tuffs, Karine Dufresne, Aanchal Rishi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 6, pp. 417-434
Closed Access | Times Cited: 20
Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series
Marijke Peetermans, Veerle Matheeussen, Cedric Moerman, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 20
A brief review on Group A Streptococcus pathogenesis and vaccine development
Sowmya Ajay Castro, Helge C. Dorfmueller
Royal Society Open Science (2021) Vol. 8, Iss. 3
Open Access | Times Cited: 61
Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK
Rebecca Cordery, Amrit Kaur Purba, Lipi Begum, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 5, pp. e366-e375
Open Access | Times Cited: 51
Group A streptococcal (GAS) infections amongst children in Europe: Taming the rising tide
Nityanand Jain, Édouard Lansiaux, Aigars Reinis
New Microbes and New Infections (2022) Vol. 51, pp. 101071-101071
Open Access | Times Cited: 39
Emerging Invasive Group A Streptococcus M1UK Lineage Detected by Allele-Specific PCR, England, 20201
Xiangyun Zhi, Ho Kwong Li, Hanqi Li, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 5
Open Access | Times Cited: 37
Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1UK, Belgium, May 2022 to August 2023
Juan Pablo Rodríguez-Ruiz, Qiang Lin, Christine Lammens, et al.
Eurosurveillance (2023) Vol. 28, Iss. 36
Open Access | Times Cited: 34
Group A Streptococcal Meningitis With the M1UK Variant in the Netherlands
Boas C.L. van der Putten, Bart J. M. Vlaminckx, Brechje de Gier, et al.
JAMA (2023) Vol. 329, Iss. 20, pp. 1791-1791
Open Access | Times Cited: 33
Characterization of emergent toxigenic M1UK Streptococcus pyogenes and associated sublineages
Ho Kwong Li, Xiangyun Zhi, Ana Vieira, et al.
Microbial Genomics (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 32
Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak
Eva Ramírez de Arellano, Jesús Saavedra‐Lozano, Pilar Villalón, et al.
mSphere (2024) Vol. 9, Iss. 3
Open Access | Times Cited: 15
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization
Davide Mangioni, Valeria Fox, Paola Saltini, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 10
Detection of toxigenic M1UK lineage group A Streptococcus clones in Taiwan
Chuan Chiang-Ni, Chih-Yün Hsü, Yu-Hsuan Yeh, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 2, pp. 269-277
Open Access | Times Cited: 9
Increase in invasive Streptococcus pyogenes M1 infections with close evolutionary genetic relationship, Iceland and Scotland, 2022 to 2023
Stephen B. Beres, Randall J. Olsen, S. Wesley Long, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 9
Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009–2023, the Netherlands: a molecular epidemiological study
Lidewij W. Rümke, Matthew Davies, Stefan M.T. Vestjens, et al.
Journal of Clinical Microbiology (2024) Vol. 62, Iss. 10
Open Access | Times Cited: 9
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
Matthew Davies, Brechje de Gier, Rebecca Guy, et al.
Emerging infectious diseases (2025) Vol. 31, Iss. 2
Open Access | Times Cited: 1
Recombinant production platform for Group A Streptococcus glycoconjugate vaccines
Sowmya Ajay Castro, Ian J. Passmore, Didier Ndeh, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Genomic interrogation of invasive group A Streptococcus (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective study
Jacqueline M. Morris, Jake A. Lacey, Kerrie Stevens, et al.
The Lancet Regional Health - Western Pacific (2025) Vol. 55, pp. 101467-101467
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top